The current cost of heart failure to the National Health Service in the UK

European Journal of Heart Failure

Volumn 4, Issue 3, 2002, Pages 361-371

  Stewart, Simon ^a   Jenkins, Andrew ^b   Buchan, Scot ^b   McGuire, Alistair ^c   Capewell, Simon ^d   McMurray, John J J V ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b Strategen Ltd   (United Kingdom)

^c CITY UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Cost evaluation; Heart failure; Hospitalisation; Morbidity

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM ANTAGONIST; CARDIAC GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE;

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; CONSULTATION; CONTROLLED STUDY; COST CONTROL; FEMALE; GENDER; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEART FAILURE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; NURSING HOME; OUTPATIENT; PATIENT REFERRAL; PRESCRIPTION; PRIORITY JOURNAL; UNITED KINGDOM; VALIDATION PROCESS;

AGED; AGED, 80 AND OVER; COMMUNITY HEALTH SERVICES; COST OF ILLNESS; DRUG COSTS; FEMALE; GREAT BRITAIN; HEALTH CARE COSTS; HEART FAILURE, CONGESTIVE; HOSPITAL COSTS; HUMANS; MALE; MIDDLE AGED; NURSING HOMES; STATE MEDICINE;

EID: 0036623851     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(01)00198-2     Document Type: Article

References (39)

1. Garg R, Packer M, Pitt B, Yusuf S. Heart failure in the 1990s: evolution of a major public health problem in cardiovascular medicine. J Am Coll Cardiol 1993;22(Suppl A):3A-5A.
2. Bonneux L, Barendregt MA, Meeter K, Bonsel GJ, van der Maas PJ. Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure. Am J Public Health 1994;84:20-8.
3. Maclntyre K, Capewell S, Stewart S et al. Evidence of improving prognosis in heart failure: trends in case-fatality in 66547 patients hospitalised between 1986 and 1995. Circulation 2000;102:1126-31.
4. Stewart S, Maclntyre K, Hole DA, Capewell S, McMurray JJ. More malignant than cancer? Five-year survival following a first admission for heart failure in Scotland. Eur J Heart Failure 2001;3:315-22.
5. Haldeman GA, Croft JB, Giles WH, Rashidee A. Hospitalization of patients with heart failure: national hospital discharge survey 1985-1995. Am Heart J 1999;137:352-60.
6. Stewart S, Maclntyre K, McCleod ME, Bailey AE, Capewell S, McMurray JJ. Trends in heart failure hospitalisations in Scotland, 1990-1996: an epidemic that has reached its peak? Eur Heart J 2001;22:209-17.
7. McMurray JJ, Hart W, Rhodes G, An evaluation of the cost of heart failure to the National Health Service in the UK. Br J Med Econ 1993;6:91-8.
8. Rodriguez-Artalejo F, Guallar-Castillon P, Banegas Banegas JR, del Rey Calero J. Trends in hospitalization and mortality for heart failure in Spain, 1980-1993. Eur Heart J 1997;18:1771-9.
9. Ghali JK, Cooper R, Ford E. Trends in hospitalisation rates for heart failure in the United States 1973-1986: evidence for screening population prevalence. Arch Intern Med 1992;150:769-73.
10. Eriksson H, Wilhelmsen L, Caidahl K, Svardsudd K. Epidemiology and prognosis of heart failure. Z Kardiol 1991;80:1-6.
11. Doughty R, Yee T, Sharpe N et al. Hospital admissions and deaths due to congestive heart failure in New Zealand, 1988-1991, NZ Med J 1995;108:473-5.
12. Reitsma JB, Mosterd A, de Craen AJM et al. Increase in hospital admission rates for heart failure in the Netherlands, 1980-1993. Heart 1996;76:388-92.
13. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
14. MERIT Investigators. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (Merit-HF). Lancet 1999;353:2001-7.
15. Pitt B, Zannad F, Remme WJ et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-17.
16. McDonagh TA, Morrison CE, Lawrence A et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 1997;350:829-33.
17. Morgan S, Smith H, Simpson I et al. Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey. Br Med J 1999;318:368-72.
18. Department of Health. Health and Personal Social Services and Statistics (UK), London: Government Statistical Service, 2000.
19. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995;26:1565-74.
20. Senni M, Tribouilloy CM, Rodeheffer RJ et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998;98:2282-9.
21. http://www.show.scot.nhs.uk/isd/primary-care.
22. Royal College of General Practitioners, Office of Population Censuses and Surveys, Department of Health. Morbidity Statistics from General Practice: Fourth National Study 1991-1992. London: HMSO, 1995.
23. Mair FS, Crowley TS, Bundred PE. Prevalence, aetiology and management of heart failure in general practice. Br J Gen Pract 1996;46:77-9.
24. Lip G, Sawar S, Ahmed I et al. A survey of heart failure in general practice. Eur J Gen Pract 1997;3:85-9.
25. Clarke KW, Gray D, Hampton JR. How common is heart failure? Evidence from PACT (Prescribing Analysis and Cost) data in Nottingham. J Public Health Med 1995;17:459-64.
26. IMS Health (UK). Congestive Heart Failure, 2000.
27. Kendrick S, Clarke J, The Scottish record linkage system. Health Bull 1993;51:72-9.
28. WHO. Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death. 9th revision, 1977.
29. Harley K, Jones C. Quality of Scottish Morbidity Record (SMR) data. Health Bull 1996;54:410-17.
30. Stewart S, Blue L, Capewell S, Horowitz JD, McMurray JJ. Poles apart, but are they the same? A comparative study of Australian and Scottish patients with chronic heart failure. Eur J Heart Failure 2001;3:249-55.
31. Office of Health Economics. 10th Compendium of Health Statistics. London: Office of Health Economics, 1997.
32. National Health Service in Scotland. Scottish Health Service Costs. Edinburgh: Information and Statistics Division, 1996.
33. Community Care Costs. PSSRU, University of Kent, 1998.
34. http://www.bankofengland.co.uk/inflationreport/index.htm.
35. Packer M, Poole-Wilson PA, Armstrong PW et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation 1999;100:2312-8.
36. Rydén-Bergsten T, Andersson F. The healthcare costs of heart failure in Sweden. J Intern Med 1999;246:275-84.
37. Dale S. Stroke. London: Office of Health Economics, 1989.
38. Laing W. The cost of diet-related disease. In: Turner M, editor. Preventative Nutrition. London: Academic Press, 1989.
39. Griffin J, Wyles M. Epilepsy: Towards Tomorrow. London: Office of Health Economics, 1991.